国产在线拍偷自揄拍无码,欧美成人精品高清在线观看,又粗又黄又爽视频免费看,亚洲精品一区二区久久

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

我和黑帮老大的365天| 中文av人妻av无码中文| 白嫩日本少妇做爰| 久久综合久久鬼色| 污视频在线观看| 无码a∨高潮抽搐流白浆| 王妃暗卫肉h共妻大肉| 亚洲一区自拍高清亚洲精品| 五月香丁激情欧美啪啪| 国产深夜男女无套内射| 亚洲人成无码WWW久久久| 国产精品另类激情久久久免费| 永久免费的啪啪网站免费观看浪潮| 娇妻穿丁字裤公交车被c| 亚洲国产成人精品女人久久久 | 国产毛多水多做爰爽爽爽| 色噜噜狠狠色综合av肉乳乱| 三个黑人跟一个女人xxoo| 亚洲综合无码一区二区三区加勒比| 亚洲樱花大片| 丝袜灬啊灬快灬高潮了AV| 扒开粉嫩小泬舌头伸进去 | aa片在线观看视频在线播放| 亚洲精品~无码抽插| 亚洲精品国产摄像头| 99蜜桃在线观看免费视频网站 | 亚洲第一综合天堂另类专| 边做饭边被躁bd在线播放| 亚洲精品久久久久久不卡| 国产av国片偷人妻麻豆| 无套内谢少妇毛片a片999| 强开小婷嫩苞又嫩又紧视频| 久久亚洲美女精品国产精品| 久久精品噜噜噜成人av| 公车系强女奷校花雪柔| 无码丰满熟妇juliaann与黑人| 色欲无码国产喷水av精品| 国产精品亚洲lv粉色| 中国男同gay片| 国产AV一区二区精品凹凸| 国产v亚洲v天堂无码久久久|